UK plays safe on risks from blood products

Asako Saegusa

Nature, 1998, vol. 392, issue 6671, 3-3

Abstract: london The British government has advised against the use of UK plasma in blood products, in order to protect patients receiving the products against the ‘theoretical risk’ of contracting the new variant of Cretzfeldt-Jakob disease.

Date: 1998
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/31992 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:392:y:1998:i:6671:d:10.1038_31992

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/31992

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().